Raghavendra Devadiga

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Cell Proliferation

Top Venues

Journal of Korean medical science

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Amit B Bhavsar, Janusz Zaryczański, Anna Wasilewska, Delphine Saragoussi, Raghavendra Devadiga, Chris Colby, Enas Bahar, Jacek Wysocki
Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine. Human vaccines & immunotherapeutics (2022)
Hee Jin Park, Sung Jin Kim, Katerina Rok Song, Jing Shen, Joon-Hyung Kim, Raghavendra Devadiga, Hee-Cheol Kang
A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea. Journal of Korean medical science 34 (12) (2019)